Health Condition 1: Z018- Encounter for other specified special examinations
Conditions
Interventions
Intervention1: Sugammadex: Dosage: 2 mg/kg IV bolus (adjusted according to actual body weight, given at reappearance of T2 in TOF monitoring)
Route: Intravenous (IV)
Frequency: Single dose at the en
Sponsors
Indraprastha Apollo Hospital, New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: ASA (American Society of Anaesthesiologists), physical status 1 and 3 Age more than 18 years Any surgical procedure under general anesthesia with rocuronium and requiring reversal
Exclusion criteria
Exclusion criteria: Hypersensitivity to any drugs/cyclodextrins Difficult intubation Neuromuscular disorder/neurodegenerative disorders Severe renal and hepatic dysfunction History of Malignant hyperthermia Pregnancy Chronic obstructive airway disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time required to reach train of four ratio to 0.9 after the administration of sugammadex or neostigmineTimepoint: Every 15 minutes till TOF more than equal to 0.9 and at 2 hours after extubation | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative residual paralysis, Adverse effects of neostigmine and sugammadexTimepoint: At 2 hours after extubation | — |
Countries
India
Contacts
Public ContactDharitri Dutta
Indraprastha Apollo Hospital, New Delhi
Outcome results
None listed